Bristol Myers Squibb (CELG-RI) Net Cash Flow (QoQ) (2009 - 2026)

Bristol Myers Squibb (CELG-RI) Net Cash Flow (QoQ) (2009 - 2026) Analysis & Trends

Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn
10 Bristol Myers Squibb - - 8.07 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 89.35%
Dec 31, 2025 -276.76%
Sep 30, 2025 93.97%
Jun 30, 2025 248.05%
Mar 31, 2025 -82.24%
Dec 31, 2024 71.12%
Sep 30, 2024 150.40%
Jun 30, 2024 -40.93%
Mar 31, 2024 -155.25%
Dec 31, 2023 572.89%
Sep 30, 2023 -33.17%
Jun 30, 2023 -112.07%
Mar 31, 2023 -122.78%
Dec 31, 2022 143.34%
Sep 30, 2022 -89.73%
Jun 30, 2022 11.34%
Mar 31, 2022 -455.60%
Dec 31, 2021 -80.44%
Sep 30, 2021 4,227.59%
Jun 30, 2021 101.60%